The Value of Grip Test, Lysophosphatidlycholines, Glycerophosphocholine, Ornithine, Glucuronic Acid Decrement in Assessment of Nutritional and Metabolic Characteristics in Hepatitis B Cirrhosis

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2017 Apr 7

PMID 28384211

Citations 6

Authors

Qing Ye

Weili Yin

Lei Zhang

Huijuan Xiao

Yumei Qi

Shuye Liu

Baoxin Qian

Fengmei Wang

Tao Han

Affiliations

Soon will be listed here.

Abstract

The liver is essential for the regulation of energy, protein and amino acids, as well as in other aspects of metabolism. To identify efficient indexes for evaluation of nutritional status and metabolic characteristics during different Child-Pugh stages of hepatitis B cirrhosis, 83 patients and 35 healthy individuals were enrolled in our study. We found that grip strength, triceps skinfold thickness (TSF), body fat and skeletal muscle of the patients were reduced compared to the control group (P<0.05). Ultra-high-performance liquid chromatography data combined with mass spectrometry (UPLC-MS) showed that levels of a variety of metabolites, including lysophosphatidylcholines (LysoPCs), glycerophosphocholine, ornithine and glucuronic acid were reduced in the serum of patients with hepatitis B cirrhosis (P<0.001). However, glycerophosphoserine and taurocholic acid levels were higher than in the control group (P<0.001). Moreover, grip strength was correlated with the Child-Pugh score (P<0.05). Serum albumin, total cholesterol, LDL, LysoPCs, glycerophosphocholine, ornithine, glucuronic acid, glycerophosphoserine and taurocholic acid were correlated with the Child-Pugh score (P<0.01). These findings suggested that grip strength and the above small molecular substances might be considered as sensitive and important indexes for evaluating nutritional status and metabolic characteristics of patients with hepatitis B cirrhosis, which may help assess prognosis and adjust nutritional treatment.

Citing Articles

Metabolomic and transcriptomic profiling reveals the effect of dietary protein and lipid levels on growth performance in loach ().

Wang Z, Li S, Zhang Y, Li Y, Huo H, Yu C Front Immunol. 2023; 14:1236812.

PMID: 37593743 PMC: 10431964. DOI: 10.3389/fimmu.2023.1236812.

Predictive value of serum bile acids as metabolite biomarkers for liver cirrhosis: a systematic review and meta-analysis.

Han X, Wang J, Gu H, Guo H, Cai Y, Liao X Metabolomics. 2022; 18(7):43.

PMID: 35759044 DOI: 10.1007/s11306-022-01890-y.

Nutrition and metabolism status alteration in advanced hepatocellular carcinoma patients treated with anti-PD-1 immunotherapy.

Jiang Y, Tu X, Zhang X, Liao H, Han S, Jiang W Support Care Cancer. 2020; 28(11):5569-5579.

PMID: 32361828 DOI: 10.1007/s00520-020-05478-x.

Dietary protein sources and disease severity, malnutrition and anthropometric measurements in cirrhotic patients.

Pashayee-Khamene F, Kord-Varkaneh H, Saber-Firoozi M, Hatami B, Rashidkhani B, Hekmatdoost A Gastroenterol Hepatol Bed Bench. 2019; 12(2):143-148.

PMID: 31191839 PMC: 6536023.

Non-invasive urinary metabolomic profiles discriminate biliary atresia from infantile hepatitis syndrome.

Li W, Yang Y, Dai Q, Lin L, Xie T, He L Metabolomics. 2019; 14(7):90.

PMID: 30830373 DOI: 10.1007/s11306-018-1387-z.

References

Goldstein J, Brown M . Regulation of the mevalonate pathway. Nature. 1990; 343(6257):425-30. DOI: 10.1038/343425a0. View

Matoori S, Leroux J . Recent advances in the treatment of hyperammonemia. Adv Drug Deliv Rev. 2015; 90:55-68. DOI: 10.1016/j.addr.2015.04.009. View

Seijo S, Lozano J, Alonso C, Miquel R, Berzigotti A, Reverter E . Metabolomics as a diagnostic tool for idiopathic non-cirrhotic portal hypertension. Liver Int. 2015; 36(7):1051-8. DOI: 10.1111/liv.12972. View

Fernandes S, de Mattos A, Tovo C, Marroni C . Nutritional evaluation in cirrhosis: Emphasis on the phase angle. World J Hepatol. 2016; 8(29):1205-1211. PMC: 5067440. DOI: 10.4254/wjh.v8.i29.1205. View

Xiong J, Huang J, Sun W, Wang J, Chen D . Non-alcoholic steatohepatitis-related liver cirrhosis is increasing in China: a ten-year retrospective study. Clinics (Sao Paulo). 2015; 70(8):563-8. PMC: 4518765. DOI: 10.6061/clinics/2015(08)06. View

Carvalho L, Parise E . Evaluation of nutritional status of nonhospitalized patients with liver cirrhosis. Arq Gastroenterol. 2007; 43(4):269-74. DOI: 10.1590/s0004-28032006000400005. View

Wang X, Xie G, Zhao A, Zheng X, Huang F, Wang Y . Serum Bile Acids Are Associated with Pathological Progression of Hepatitis B-Induced Cirrhosis. J Proteome Res. 2015; 15(4):1126-34. PMC: 5660916. DOI: 10.1021/acs.jproteome.5b00217. View

Zhao Y, Wu S, Liu S, Zhang Y, Lin R . Ultra-performance liquid chromatography-mass spectrometry as a sensitive and powerful technology in lipidomic applications. Chem Biol Interact. 2014; 220:181-92. DOI: 10.1016/j.cbi.2014.06.029. View

Alvares-da-Silva M, Reverbel da Silveira T . Comparison between handgrip strength, subjective global assessment, and prognostic nutritional index in assessing malnutrition and predicting clinical outcome in cirrhotic outpatients. Nutrition. 2005; 21(2):113-7. DOI: 10.1016/j.nut.2004.02.002. View

10.

Ritter L, Gazzola J . [Nutritional evaluation of the cirrhotic patient: an objective, subjective or multicompartmental approach?]. Arq Gastroenterol. 2006; 43(1):66-70. DOI: 10.1590/s0004-28032006000100016. View

11.

Carretero A, Leon Z, Garcia-Canaveras J, Zaragoza A, Gomez-Lechon M, Donato M . In vitro/in vivo screening of oxidative homeostasis and damage to DNA, protein, and lipids using UPLC/MS-MS. Anal Bioanal Chem. 2014; 406(22):5465-76. DOI: 10.1007/s00216-014-7983-5. View

12.

Johnson T, Overgard E, Cohen A, DiBaise J . Nutrition assessment and management in advanced liver disease. Nutr Clin Pract. 2013; 28(1):15-29. DOI: 10.1177/0884533612469027. View

13.

Tietge U, Boker K, Bahr M, Weinberg S, Pichlmayr R, Schmidt H . Lipid parameters predicting liver function in patients with cirrhosis and after liver transplantation. Hepatogastroenterology. 1999; 45(24):2255-60. View

14.

Periyalwar P, Dasarathy S . Malnutrition in cirrhosis: contribution and consequences of sarcopenia on metabolic and clinical responses. Clin Liver Dis. 2012; 16(1):95-131. PMC: 4383161. DOI: 10.1016/j.cld.2011.12.009. View

15.

Rachakonda V, Borhani A, Dunn M, Andrzejewski M, Martin K, Behari J . Serum Leptin Is a Biomarker of Malnutrition in Decompensated Cirrhosis. PLoS One. 2016; 11(9):e0159142. PMC: 5008824. DOI: 10.1371/journal.pone.0159142. View

16.

Haverkort E, Reijven P, Binnekade J, De van der Schueren M, Earthman C, Gouma D . Bioelectrical impedance analysis to estimate body composition in surgical and oncological patients: a systematic review. Eur J Clin Nutr. 2014; 69(1):3-13. DOI: 10.1038/ejcn.2014.203. View

17.

Cheung K, Lee S, Raman M . Prevalence and mechanisms of malnutrition in patients with advanced liver disease, and nutrition management strategies. Clin Gastroenterol Hepatol. 2011; 10(2):117-25. DOI: 10.1016/j.cgh.2011.08.016. View

18.

Pirlich M, Schutz T, Spachos T, Ertl S, Weiss M, Lochs H . Bioelectrical impedance analysis is a useful bedside technique to assess malnutrition in cirrhotic patients with and without ascites. Hepatology. 2000; 32(6):1208-15. DOI: 10.1053/jhep.2000.20524. View

19.

Kyle U, Bosaeus I, De Lorenzo A, Deurenberg P, Elia M, Gomez J . Bioelectrical impedance analysis--part I: review of principles and methods. Clin Nutr. 2004; 23(5):1226-43. DOI: 10.1016/j.clnu.2004.06.004. View

20.

Ruiz-Margain A, Macias-Rodriguez R, Duarte-Rojo A, Rios-Torres S, Espinosa-Cuevas A, Torre A . Malnutrition assessed through phase angle and its relation to prognosis in patients with compensated liver cirrhosis: a prospective cohort study. Dig Liver Dis. 2015; 47(4):309-14. DOI: 10.1016/j.dld.2014.12.015. View